# Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE)

> **NCT01101802** · PHASE4 · COMPLETED · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 71 (actual)

## Conditions studied

- Systemic Lupus Erythematosus
- Atherosclerosis

## Interventions

- **DRUG:** Mycophenolate mofetil
- **DRUG:** sugar pill

## Key facts

- **NCT ID:** NCT01101802
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-03
- **Final completion:** 2008-10
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2011-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101802, "Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01101802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*